FLUOXETINE HCL
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
LEGACY PHARMACE
Indication
Depression associated with bipolar disorder, adjunct treatment
Depression associated with bipolar disorder, adjunct treatment refers to the management of acute major depressive episodes in patients diagnosed with bipolar I or bipolar II disorder as an add-on therapy to primary mood-stabilizing or atypical antipsychotic regimens. Read more about Depression associated with bipolar disorder, adjunct treatment
107 drugs 70 manufacturers
Drugs that treat it
Common Depression associated with bipolar disorder, adjunct treatment therapies.
FLUOXETINE HCL
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
TEVA USA
PROZAC (fluoxetine HCl)
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
Dista Products Company
SARAFEM (fluoxetine HCl)
MAJOR DEPRESSIVE DISORDER·+5
WC PROF PRODS
FLUOXETINE HCL
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
PAR HEALTH USA,
FLUOXETINE (fluoxetine HCl)
MAJOR DEPRESSIVE DISORDER·+5
APOTEX CORP
FLUOXETINE HCL
MAJOR DEPRESSIVE DISORDER·+5
SILARX PHARM
FLUOXETINE HCL
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
PHARMACEU ASSOC
OLANZAPINE ODT (olanzapine)
SCHIZOPHRENIA·+3
PAR HEALTH USA,
Filter & compare in the drug finder →Opens the drug finder with Depression associated with bipolar disorder, adjunct treatment preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDepression associated with bipolar disorder, adjunct treatment refers to the management of acute major depressive episodes in patients diagnosed with bipolar I or bipolar II disorder as an add-on therapy to primary mood-stabilizing or atypical antipsychotic regimens.
Primarily affecting the central nervous system, this psychiatric state is characterized by persistent depressed mood, anhedonia, psychomotor slowing, cognitive deficits, and elevated suicidal risk occurring within the context of a cyclic mood disorder.
Pathophysiologically driven by dysregulation in monoaminergic neurotransmission, neuroplastic signaling pathways, and frontolimbic neural circuits, adjunctive intervention targets residual depressive symptoms when baseline mood-stabilizing monotherapy proves insufficient, while mitigating the risk of precipitating treatment-emergent manic or hypomanic switches.
- nih.gov
Depression associated with bipolar disorder, adjunct treatment refers to the management of acute major depressive episodes in patients diagnosed with bipolar I or bipolar II disorder as an add-on therapy to primary mood-stabilizing or atypical antipsychotic regimens Primarily affecting the central nervous system, this psychiatric state is characterized by persistent depressed mood, anhedonia, psychomotor slowing, cognitive deficits, and elevated suicidal risk occurring within the context of a cy...
- lakedelavanhouse.com
Depression associated with bipolar disorder, adjunct treatment refers to the management of acute major depressive episodes in patients diagnosed with bipolar I or bipolar II disorder as an add-on therapy to primary mood-stabilizing or atypical antipsychotic regimens Primarily affecting the central nervous system, this psychiatric state is characterized by persistent depressed mood, anhedonia, psychomotor slowing, cognitive deficits, and elevated suicidal risk occurring within the context of a cy...
- advancedpsychiatryassociates.com
Primarily affecting the central nervous system, this psychiatric state is characterized by persistent depressed mood, anhedonia, psychomotor slowing, cognitive deficits, and elevated suicidal risk occurring within the context of a cyclic mood disorder
- nih.gov
Pathophysiologically driven by dysregulation in monoaminergic neurotransmission, neuroplastic signaling pathways, and frontolimbic neural circuits, adjunctive intervention targets residual depressive symptoms when baseline mood-stabilizing monotherapy proves insufficient, while mitigating the risk of precipitating treatment-emergent manic or hypomanic switches
- washington.edu
Pathophysiologically driven by dysregulation in monoaminergic neurotransmission, neuroplastic signaling pathways, and frontolimbic neural circuits, adjunctive intervention targets residual depressive symptoms when baseline mood-stabilizing monotherapy proves insufficient, while mitigating the risk of precipitating treatment-emergent manic or hypomanic switches
Personalize your experience
Follow Depression associated with bipolar disorder, adjunct treatment and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.